Come and join  Omixon for a breakfast seminar at to learn about the benefits of using next generation sequencing  for transplantation genetics.

You will learn how to reduce ambiguity, increase resolution of HLA typing at an affordable price point. The presentation will also address the challenges current early adopters face with NGS and its limitations and how current developments address these challenges.

The session will be held by the CEO of Omixon, Attila Bérces, PhD.

If you would like to join, please, send an email: hajnalka.hejja@omixon.com

When?

08.00 AM, 14th February, 2013

Where?

Room 254C, Salt Palace Convention Center, 100 SW Temple, Salt Lake City, UT 84101